WV | DHHR | BPH | OEHP | DSDC | IDEP | A-Z Link

West Virginia
Infectious Disease Epidemiology Program

Provider FAQ:

Bioterrorism

View or print printer-friendly PDF file (requires Adobe Acrobat 3.0 or greater)

 

West Virginia Department of Health and Human Resources Information for Physicians - Bioterrorism

How likely is a bioterrorist (BT) event in West Virginia?

We have no information to suggest that a true BT event is likely in our state; however, no one can really predict what a criminal will do next. Therefore, we must all remain alert. The purpose of this information sheet is to quickly inform physicians about the clinical and public health issues surrounding BT.

What should I be watching for?

It is thought that BT agents would most likely be disseminated covertly via aerosol. That is, severe human illness would be the first sign that a BT event has occurred. Here is a brief run-down of the most serious BT agents.

Agent Clinical Clues Epidemiological Clues
Anthrax Influenza-like prodrome with rapid progression to death within 1-3 days

Abnormal chest x-ray, including widened mediastinum and/or pulmonary infiltrate or effusion

Cluster of respiratory disease in previously healthy individuals with rapid progression to death

Incubation 2-60 days

Pneumonic plague Severe rapidly progressive pneumonia with death in 2-6 days Cluster of pneumonia in previously healthy individuals with rapid progression to death

Incubation 1-6 days, usually 2-4 days

Tularemia Abrupt onset of fever, headache, chills, rigors

Progression to pneumonia in some patients

Cluster of respiratory illness with progression to pneumonia in previously healthy individuals, especially off-season

Incubation 1-14 days, usually 3-5 days

Smallpox Prodrome of high fever, malaise, prostration

Maculopapular rash with progression to round, tense pustules, deeply embedded in the dermis and most prominent on the face and extremities

Cluster of patients with characteristic rash illness

Incubation 7-17 days, usually 12-14 days

Botulinium toxin Acute, afebrile, descending flaccid paralysis that always begins in the bulbar muscles

Death may result from airway and respiratory muscle paralysis 

Cluster of patients with multiple cranial nerve abnormalities

Incubation probably 1-5 days

What should I do if I suspect an unusual event?

Notify your hospital infection control practitioner and local health department immediately. Do not wait for results of a diagnostic test if a cluster of unusual illness is identified. Rapid investigation will be necessary to establish whether an event occurred, which persons were exposed, and whether exposed persons would benefit from prophylactic immunizations or antibiotics. For some agents with the potential for secondary spread (e.g., smallpox, pneumonic plague), isolation or quarantine of ill persons will be necessary to stop transmission.

What should I do about diagnostic testing for BT agents?

Notify the Infectious Disease Epidemiology Program (IDEP) immediately if a case or cluster of suspicious disease is identified. The IDEP phone number is 304-558-5358 or 800-423-1271 from 8:30 to 5:00 and beeper 1-888-882-5135 at any time. For specific questions about diagnostic tests, call the Office of Laboratory Services at 304-558-3530 from 8:00 to 5:00.

What other agents are possible?

Brucellosis, cholera, glanders, Q fever, Venezuelan equine encephalitis, and viral hemorrhagic fevers are among the agents that might be weaponized. In each case, a BT attack would first present as a cluster of unusual illness affecting previously healthy individuals.

What do I tell my patients?

The West Virginia Department of Health and Human Resources has prepared information for the public on bioterrorism. Contact your local health department for a copy of an information sheet on bioterrorism suitable for a general audience, or visit the website at www.wvdhhr.org/bph/oehp/sdc/bioterrorism.htm.

Reassure your patients that we have no information to suggest a bioterrorist attack is likely, but smallpox vaccine and antibiotics are stockpiled in the unlikely event that an attack occurs.

Do not prescribe antibiotics for patients to prevent illness. There is no single antibiotic that will cover all BT agents, and the combination of side effects and antibiotic mis-use may do more harm than good. Smallpox vaccine is not available for general use because the supply is limited, the risk of smallpox is small, and the vaccine may have significant side effects.

Discourage patients from purchase of gas masks. A gas mask is only effective if worn at the time of aerosol release. Since aerosol release is unlikely to be announced in advance, a mask would have to be worn 24 hours a day and 7 days a week indefinitely to confer protection.

Patients who are unduly preoccupied or obsessing about this issue may benefit from counseling or participation in a support group.

Where can I get more information?

JAMA has been running a series of articles summarizing recommendations for medical and public health management of biological weapons attacks. These excellent articles are found on the following website or in hard copy: http://www.hopkins-biodefense.org/

Tularemia: JAMA, 2001; 285:2763-2773.
Botulinium Toxin: JAMA, 2001; 285:1059-1070.
Plague: JAMA, 2000; 283:2281-2290.
Smallpox: JAMA, 1999; 281:2127-2137.
Anthrax: JAMA, 1999; 281:1735-1745.

 


State of West Virginia (WV)
West Virginia Department of Health and Human Resources (DHHR)
Bureau for Public Health (BPH)
Office of Epidemiology and Health Promotion (OEHP)
Division of Surveillance and Disease Control (DSDC)
Infectious Disease Epidemiology Program (IDEP)

A-Z Listing of West Virginia's Reportable Diseases



This FAQ was last updated December 2001.
If you have questions or comments about the West Virginia Division of Surveillance and Disease Control, please direct them to Loretta Haddy at Loretta.E.Haddy@wv.gov. If you have questions or comments about this Web page, please direct them to Betty Jo Tyler at Betty.J.Tyler@wv.gov.

 

This page has been visited Hit Counter times.